跳至主要内容
临床试验/NL-OMON42745
NL-OMON42745已完成不适用

Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs to detect Atrial Fibrillation - MOBILE-AF trial

eids Universitair Medisch Centrum0 个研究点目标入组 57 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
57

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patient with cryptogenic stroke
  • Patient with cryptogenic TIA

排除标准

  • - Known etiology of TIA or stroke
  • - Myocardial infarction <6 months before stroke
  • - Coronary Artery Bypass Grafting <6 months before stroke
  • - Severe valvular heart disease
  • - Documented history of atrial fibrillation or atrial flutter
  • - Permanent indication for oral anticoagulation at enrolment
  • - Patient has permanent OAC contraindication
  • - Patient is included in another randomized trial
  • - Left ventricular aneurysm on echocardiography
  • - Thrombus on echocardiographyRenal dysfunction (creatinine clearance <30 mL/min/1.73m2)
  • - Patient has life expectancy of <1 year
  • - Patient is not willing to sign the informed consent form
  • - Patient is <18 years of age
  • - Patient is considered a incapacitated adult
  • - Patient is not in possession of a smartphone with Android Operating System (OS) or iOS.

研究者

相似试验